查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475203

全球生物安全檢測產品和服務市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Biological Safety Testing Products And Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 236 Pages | 商品交期: 最快1-2個工作天內

價格

全球生物安全檢測產品和服務市場的需求預計將從2023年的50.1億美元達到2032年的近128.8億美元，2024-2032年研究期間的複合年成長率為11.06%。

生物安全檢測產品和服務包括一系列用於評估疫苗、單株抗體、細胞療法、基因療法和重組蛋白等生物製藥產品的安全性、純度和效力的測定、試劑、消耗品、設備和實驗室服務。這些產品和服務對於確保遵守監管機構（包括美國食品和藥物管理局 (FDA) 和歐洲藥品管理局 (EMA)）制定的監管要求和品質標準至關重要。生物安全測試涉及透過細胞測定、分子測定、免疫測定、微生物測定和生物測定來評估生物製品中是否存在污染物、毒素、外來物質和雜質。

市場動態

對生物藥物、疫苗和生物製劑不斷成長的需求推動了對原料、中間產品和最終製劑進行嚴格測試的需要，以確保其臨床使用的安全性、純度和有效性。隨著生物製藥研發的興起、新型生物製劑和生物相似藥的開發以及藥品供應鏈的日益全球化等因素，人們越來越重視綜合測試方案、風險緩解策略和品質控制措施，以應對新出現的生物危害、污染風險和監管要求。此外，分析技術、基於細胞的測定和分子生物學方法的進步使得創新的生物安全檢測產品和服務的開發成為可能，這些產品和服務可以對生物製藥產品和製造中的微生物污染物、外來物質和雜質進行靈敏、特異且可靠的檢測流程。

此外，擴大採用體外和體內測試方法，例如細胞培養測定、核酸擴增技術和動物模型，推動了生物安全測試產品和服務市場的創新，因為公司尋求成本效益、高通量和預測測試平台可簡化產品開發、加速監管核准並確保病患安全。此外，生物製藥產品、製造流程和監管要求日益複雜，推動了市場對專業測試服務、諮詢和外包解決方案的需求。然而，監管要求、技術進步和安全標準日益複雜可能會挑戰未來幾年生物安全檢測產品和服務市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球生物安全檢測產品和服務市場的各個細分市場進行包容性評估。生物安全檢測產品和服務業的成長和趨勢為本研究提供了整體方法。

市場區隔

生物安全檢測產品和服務市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 試劑和試劑盒
  • 服務
  • 儀器

按申請

  • 疫苗及治療藥物（疫苗、單株抗體、重組蛋白）
  • 血液和血液製品
  • 基因治療
  • 組織和組織基產品
  • 幹細胞

按測試類型

  • 內毒素測試
  • 無菌測試
  • 細胞株驗證和表徵測試
  • 生物負載測試
  • 外來因子檢測測試
  • 殘留宿主污染檢測測試
  • 其他

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲生物安全檢測產品和服務市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物安全檢測產品和服務市場的主要參與者包括 Charles River Laboratories、BSL Bioservice、Merck KGaA (MilliporeSigma)、Samsung Biologics、Sartorius AG、Eurofins Scientific、SGS Societe Generale de Surveillance SA、Thermo Fisher Scientific Inc.、Biomerieux、龍沙。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：生物安全檢測產品與服務 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按測試類型進行的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球生物安全檢測產品與服務市場分析：按產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 試劑和試劑盒
  • 服務
  • 儀器

第 6 章：全球生物安全檢測產品與服務市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 疫苗及治療藥物（疫苗、單株抗體、重組蛋白）
  • 血液和血液製品
  • 基因治療
  • 組織和組織基產品
  • 幹細胞

第 7 章：全球生物安全測試產品與服務市場分析：依測試類型

  • 按測試類型概述
  • 歷史和預測數據
  • 按測試類型分析
  • 內毒素測試
  • 無菌測試
  • 細胞株驗證和表徵測試
  • 生物負載測試
  • 外來因子檢測測試
  • 殘留宿主污染檢測測試
  • 其他

第 8 章：全球生物安全檢測產品與服務市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：生物安全偵測產品與服務公司的競爭格局

  • 生物安全檢測產品與服務市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Charles River Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BSL Bioservice
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck KGaA (MilliporeSigma)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Samsung Biologics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sartorius AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Eurofins Scientific
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • SGS SocieTe GeNeRale De Surveillance SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BiomeRieux
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lonza
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114348

The global demand for Biological Safety Testing Products And Services Market is presumed to reach the market size of nearly USD 12.88 Billion by 2032 from USD 5.01 Billion in 2023 with a CAGR of 11.06% under the study period 2024 - 2032.

Biological safety testing products and services encompass a range of assays, reagents, consumables, equipment, and laboratory services used for assessing the safety, purity, and potency of biopharmaceutical products such as vaccines, monoclonal antibodies, cell therapies, gene therapies, and recombinant proteins. These products & services are crucial for ensuring compliance with regulatory requirements and quality standards set forth by regulatory agencies, including the U.S. Food and Drug Administration (FDA) & the European Medicines Agency (EMA). Biological safety testing involves evaluating the presence of contaminants, toxins, adventitious agents, and impurities in biological products through cell-based assays, molecular assays, immunoassays, microbiological assays, and bioassays.

MARKET DYNAMICS

The growing demand for biological drugs, vaccines, and biologics drives the need for rigorous testing of raw materials, intermediate products, and final formulations to ensure their safety, purity, and efficacy for clinical use. With factors such as the rise in biopharmaceutical R&D, the development of novel biologics and biosimilars, and the increasing globalization of pharmaceutical supply chains, there is a growing emphasis on comprehensive testing protocols, risk mitigation strategies, and quality control measures to address emerging biological hazards, contamination risks, and regulatory requirements. Additionally, advancements in analytical techniques, cell-based assays, and molecular biology methods enable the development of innovative biological safety testing products and services that offer sensitive, specific, and reliable detection of microbial contaminants, adventitious agents, and impurities in biopharmaceutical products and manufacturing processes.

Moreover, the increasing adoption of in vitro and in vivo testing methods, such as cell culture assays, nucleic acid amplification techniques, and animal models, drives biological safety testing products and services market innovation as companies seek cost-effective, high-throughput, and predictive testing platforms that streamline product development, accelerate regulatory approval, and ensure patient safety. Furthermore, the growing complexity of biopharmaceutical products, manufacturing processes, and regulatory requirements drives market demand for specialized testing services, consultancy, and outsourcing solutions. However, the increasing complexity of regulatory requirements, technological advancements, and safety standards may challenge the growth of the biological safety testing products and services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biological safety testing products and services. The growth and trends of biological safety testing products and services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the biological safety testing products and services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagents & Kits
  • Services
  • Instruments

By Application

  • Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein)
  • Blood & Blood-Based Products
  • Gene Therapy
  • Tissue & Tissue-Based Products
  • Stem Cell

By Test Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication & Characterization Tests
  • Bioburden Tests
  • Adventitious Agent Detection Tests
  • Residual Host Contamination Detection Tests
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biological Safety Testing Products And Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biological Safety Testing Products And Services market include Charles River Laboratories, BSL Bioservice, Merck KGaA (MilliporeSigma), Samsung Biologics, Sartorius AG, Eurofins Scientific, SGS Societe Generale de Surveillance SA, Thermo Fisher Scientific Inc., Biomerieux, Lonza. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Test Type
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Reagents & Kits Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions
  • 5.6. Instruments Historic and Forecast Sales By Regions

6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Historic and Forecast Sales By Regions
  • 6.5. Blood & Blood-based Products Historic and Forecast Sales By Regions
  • 6.6. Gene Therapy Historic and Forecast Sales By Regions
  • 6.7. Tissue & Tissue-based Products Historic and Forecast Sales By Regions
  • 6.8. Stem Cell Historic and Forecast Sales By Regions

7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY TEST TYPE

  • 7.1. Overview By Test Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Test Type
  • 7.4. Endotoxin Tests Historic and Forecast Sales By Regions
  • 7.5. Sterility Tests Historic and Forecast Sales By Regions
  • 7.6. Cell Line Authentication & Characterization Tests Historic and Forecast Sales By Regions
  • 7.7. Bioburden Tests Historic and Forecast Sales By Regions
  • 7.8. Adventitious Agent Detection Tests Historic and Forecast Sales By Regions
  • 7.9. Residual Host Contamination Detection Tests Historic and Forecast Sales By Regions
  • 7.10. Others Historic and Forecast Sales By Regions

8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES COMPANIES

  • 9.1. Biological Safety Testing Products And Services Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Charles River Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. BSL Bioservice
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck KGaA (MilliporeSigma)
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Samsung Biologics
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Sartorius AG
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Eurofins Scientific
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. SGS SocieTe GeNeRale De Surveillance SA
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. BiomeRieux
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Lonza
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Market Sales By Geography (USD MN)
  • Blood & Blood-based Products Market Sales By Geography (USD MN)
  • Gene Therapy Market Sales By Geography (USD MN)
  • Tissue & Tissue-based Products Market Sales By Geography (USD MN)
  • Stem Cell Market Sales By Geography (USD MN)
  • Analysis By Test Type (USD MN)
  • Endotoxin Tests Market Sales By Geography (USD MN)
  • Sterility Tests Market Sales By Geography (USD MN)
  • Cell Line Authentication & Characterization Tests Market Sales By Geography (USD MN)
  • Bioburden Tests Market Sales By Geography (USD MN)
  • Adventitious Agent Detection Tests Market Sales By Geography (USD MN)
  • Residual Host Contamination Detection Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Biological Safety Testing Products And Services Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biological Safety Testing Products And Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Biological Safety Testing Products And Services Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Market Sales By Geography (USD MN)
  • Blood & Blood-based Products Market Sales By Geography (USD MN)
  • Gene Therapy Market Sales By Geography (USD MN)
  • Tissue & Tissue-based Products Market Sales By Geography (USD MN)
  • Stem Cell Market Sales By Geography (USD MN)
  • Global Market Analysis By Test Type (USD MN)
  • Endotoxin Tests Market Sales By Geography (USD MN)
  • Sterility Tests Market Sales By Geography (USD MN)
  • Cell Line Authentication & Characterization Tests Market Sales By Geography (USD MN)
  • Bioburden Tests Market Sales By Geography (USD MN)
  • Adventitious Agent Detection Tests Market Sales By Geography (USD MN)
  • Residual Host Contamination Detection Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.